CHAIR
:
SPEAKER
(S):
Edward Agne, President, Communications Strategy Group Inc.
Rebecca Peterson, Vice President Corporate Communications, Alkermes, Inc.
Andrea DiFabio, Associate General Counsel, Biogen Idec
Stephen Heuser, Reporter, Boston Globe
Description
In an industry where most programs fail and failure can have significant adverse legal and financial consequences, public companies need to be prepared to handle bad news.
Objectives:
Discuss, using a case study, the best public relations way to dealing with a disappointing clinical trial.
Suggest ways to handle investors in the face of a clinical-trial failure.
Outline legal approaches to dealing with a failure.